| Idioma original | English |
|---|---|
| Páginas (desde-hasta) | S366-S368 |
| Publicación | Translational Cancer Research |
| Volumen | 6 |
| DOI | |
| Estado | Published - mar 1 2017 |
Nota bibliográfica
Funding Information:This work was supported by the Shared Resources of the University of Kentucky Markey Cancer Center (P30CA177558), grants from NIH (CA125454 and CA188118), DoD (BC140733P1), and Mary Kay Ash Foundation.
Financiación
This work was supported by the Shared Resources of the University of Kentucky Markey Cancer Center (P30CA177558), grants from NIH (CA125454 and CA188118), DoD (BC140733P1), and Mary Kay Ash Foundation.
| Financiadores | Número del financiador |
|---|---|
| National Institutes of Health (NIH) | CA188118, CA125454 |
| U.S. Department of Defense | BC140733P1 |
| Mary Kay Ash Foundation | |
| University of Kentucky Markey Cancer Center | P30CA177558 |
ODS de las Naciones Unidas
Este resultado contribuye a los siguientes Objetivos de Desarrollo Sostenible
-
Good health and well being
ASJC Scopus subject areas
- Oncology
- Radiology Nuclear Medicine and imaging
- Cancer Research
Huella
Profundice en los temas de investigación de 'KDM1 links nuclear GSK3β to epigenetic alterations'. En conjunto forman una huella única.Citar esto
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver